Loading clinical trials...
Loading clinical trials...
Evaluate the effects of a proprietary supplement on total HDL, HDL functionality, HDL particle size and HDL particle number (HDL-P)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Metagenics, Inc.
NCT06190834 · HDL, Coronary Heart Disease
NCT02171104 · Mucopolysaccharidosis Disorders, Hurler Syndrome, and more
NCT06607159 · Weight Change, BMI, and more
NCT07130188 · TG Index, TG/HDL-C Ratio, and more
NCT01782027 · Cholesterol, HDL, Lipid Metabolism, Inborn Errors, and more
Hypertension Institute
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions